Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.30

-3.2%

1:50 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (9320)	10/22/2003 1:43:16 PM
From: Biomaven	Read Replies (1) of 52153

I'm not familiar with the British drug approval framework, but from the POZN call it sounded like a more interactive process than here, with this being a letter from something akin to an Advisory Committee asking the company for more info. They made it sound relatively routine, but I have no idea if that is accurate. Maybe Nigel or one of our other European participants can enlighten us further. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next